Can Ciplox (ciprofloxacin) cause chills?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ciprofloxacin (Ciplox) Cause Chills?

Yes, ciprofloxacin can cause chills, though this is an uncommon adverse effect that typically occurs in the context of hypersensitivity reactions or infusion-related reactions with intravenous administration.

Documented Evidence of Chills as an Adverse Effect

The FDA-approved drug label for ciprofloxacin explicitly lists chills as a recognized adverse effect, occurring in less than 1% of patients 1. Specifically, chills are categorized under skin/hypersensitivity reactions alongside fever, flushing, and allergic reactions 1.

In clinical case reports from anthrax bioterrorism investigations, a 43-year-old female postal worker developed fever, headache, chills, and shortness of breath while being treated with levofloxacin (a related fluoroquinolone), demonstrating that chills can occur in the fluoroquinolone class 2.

Clinical Context and Mechanism

Chills associated with ciprofloxacin typically present as part of a broader reaction pattern:

  • Hypersensitivity reactions: Chills occur alongside fever, flushing, urticaria, or angioedema as manifestations of allergic response 1
  • Intravenous administration: During IV infusion, chills are more common and may be accompanied by tachycardia, hypertension, muscle pains, pyrexia, nausea, and headache 3
  • Self-limited nature: These infusion-related reactions are typically self-limited and respond to slowing the infusion rate 3

Frequency and Clinical Significance

Based on comprehensive safety data from 9,473 patients in worldwide clinical trials:

  • Overall adverse reaction incidence: 9.3% of patients 4
  • Chills specifically: <1% of patients 1
  • Most reactions (94%) were mild to moderate in severity 4
  • Only 1.5% of patients discontinued treatment due to adverse effects 4

The most common adverse effects remain gastrointestinal (nausea 2.5%, diarrhea 1.6%, vomiting 1%) and CNS-related (headache, dizziness 1.5%), with chills being considerably less frequent 1, 4.

Clinical Management Algorithm

If a patient develops chills while taking ciprofloxacin:

  1. Assess for concurrent symptoms: Check for fever, rash, urticaria, facial swelling, or respiratory symptoms suggesting hypersensitivity 1
  2. For IV administration: Slow the infusion rate immediately; most infusion-related reactions resolve with this intervention 3
  3. Rule out infection: Ensure chills are not due to progression of the underlying infection or a new infectious process 2
  4. Consider discontinuation: If chills are accompanied by signs of serious hypersensitivity (angioedema, respiratory distress, severe rash), discontinue ciprofloxacin immediately 1
  5. Document the reaction: Report to pharmacovigilance systems as chills may indicate developing hypersensitivity 5

Important Caveats

  • Chills occurring with fever and other systemic symptoms may indicate worsening infection rather than drug reaction 2
  • Patients receiving ciprofloxacin for serious infections (anthrax, neutropenic fever) may develop chills from their underlying condition 2, 6
  • The distinction between drug-related chills and infection-related chills requires clinical judgment based on timing, associated symptoms, and infection severity 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.